Abstract

Fentanyl Troche Protocol

Author(s): Roberts Bruce T

Issue: Nov/Dec 2000 - Compounding for Hormone Replacement Therapy

Page(s): 447

Download in electronic PDF format for $75
  • Fentanyl Troche Protocol Page 1

Abstract

The authors prepare a 200-microgram fentanyl troche in a 24-troche tray; it is free of preservatives and dyes that irritate the mucosal lining of sensitive patients. They compare their preparation economically with the commercially available product, which contains preservatives and dyes, and give information as to ingredients and their costs, disposable costs, clean room fee, preparation level and total price.

Related Keywords

  • clean room facility

Related Categories

  • PAIN MANAGEMENT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2000
Pg. 447
Fentanyl Troche Protocol
Author(s): Roberts Bruce T
Mar/Apr 2006
Pg. 113-119
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist
Author(s): Jeffrey Megan
Nov/Dec 2006
Pg. 436-441
Equipment, Supplies, and Facilities Required for Hospital Compounding
Author(s): McElhiney Linda F
Sep/Oct 2003
Pg. 370-371
Standard Operating Procedure: Incubator Cleaning
Author(s): Allen Loyd V Jr
Sep/Oct 2020
Pg. 426-433
Efficacy of an Automated Robotic Cleaning Device for Compounding Pharmacies
Author(s): Polonini Hudson, Dijkers Eli CF, Ferreira Anderson O, da Silva Sharlene L, Araújo Paulo Victor C, Koulouridas Savvas
Jan/Feb 2021
Pg. 18-23
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
Author(s): McKettrick Greg, Yoch Doug
Jul/Aug 2019
Pg. 281-287
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Author(s): Newton David W
Mar/Apr 2021
Pg. 94-98
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
Author(s): McKettrick Greg, Yoch Doug
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2001
Pg. 284-286
Analytical Testing Facilities and Products
Author(s): Hudson Sonora
Jul/Aug 2002
Pg. 267-270
Facilities and Procedures for Compounding Hazardous Drugs
Author(s): Rahe Hank
Mar/Apr 2000
Pg. 144
Standard Operating Procedure for Cleaning Glassware
Author(s): Allen Loyd V Jr
Mar/Apr 2014
Pg. 117-118
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities
Author(s): Miller David G
Jul/Aug 2012
Pg. 312-320
Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 1
Author(s): Zatarski Monica, Nolan Odette, Corbetti Reto
Sep/Oct 2012
Pg. 396-403
Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 2
Author(s): James Kate, Van Houtte Olivier, Ruriani Deborah, Nolan Odette, Corbetti Reto
Mar/Apr 2023
Pg. 114-121
Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility
Author(s): Summers Amy
Sep/Oct 2008
Pg. 463-466
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Author(s): Shields David E, Aclan Jennifer, Szatkowski Aaron
Jul/Aug 2007
Pg. 328
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2005
Pg. 482-483
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags
Author(s): Donnelly Ronald F
Sep/Oct 2017
Pg. 411
Fentanyl Citrate 50-mcg/mL Injection
Author(s): Allen Loyd V Jr